Parkinson's Disease

Researchers have gained new insights into largely overlooked circular RNAs in brain cells and the crucial role they play in diseases like Alzheimer’s and Parkinson’s, opening the door to developing diagnostic tests and treatments for them.

Physicists have combined nanotechnology, artificial intelligence and molecular biology to design a novel method that can detect Alzheimer’s disease protein markers in blood that are the tell-tale signs of early neurodegeneration.

A new study has revealed how the mutated proteins that are a hallmark of Parkinson’s disease spread and aggregate in the brain. The finding opens the door to developing a way of halting the disease’s progression.

A study has found that some gastrointestinal disorders are associated with an increased risk of developing Parkinson’s disease. The research provides further evidence to support the hypothesis that the neurodegenerative disorder begins in the gut.

For the first time, scientists have identified a marker in the retina that may lead to Parkinson’s disease, and it can be detected early, which could be life-changing for those at risk of developing this or other degenerative conditions.

For people with Parkinson’s disease, the simple act of walking can require constant mental vigilance, which is exhausting. Researchers have developed a free app that people with Parkinson’s can use to improve their gait and reduce the likelihood of falls.

While aging remains an unavoidable part of life, we're edging closer to therapies that could greatly improve the experience. The latest development suggests that as well as healthy aging, it can stave off neurodegenerative diseases such as Alzheimer's.

A new stem cell therapy for Parkinson’s disease, in which the donor would also become the transplant recipient, is one step closer to human trials after scientists were able to successfully grow and rebuild neurons in an animal model.

A million Americans are living with Parkinson’s disease, a neurological condition that, as it progresses, robs people of their quality of life. Now, a new mechanism has been uncovered that could potentially be treated to slow neurological decline.

We may be one step closer to developing a treatment for Parkinson’s disease, thanks to new Australian research that has discovered how a protein called optineurin works in a distinct way to clear damaged mitochondria from the brain.

Parkinson’s disease is growing rapidly, which makes its early detection so important. Researchers have developed a new machine-learning algorithm than analyzes metabolites and shows promise as a way of detecting the disease early.

A new study has found that a species of gut bacteria cause the destructive nerve cell ‘clumps’ that are a hallmark of Parkinson’s disease. The discovery opens the door to the development of targeted treatments for this debilitating disease.